{"nct_id":"NCT03302234","title":"Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)","status":"COMPLETED","status_verified_date":"2023-09","start_date":"2017-12-14","start_date_type":"ACTUAL","primary_completion_date":"2020-09-01","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}